Esperoct is a medicine used to treat and prevent bleeding in children, adolescents and adults with haemophilia A, an inherited bleeding disorder caused by the lack of factor VIII, a protein that helps the blood clot. Esperoct contains the active substance turoctocog alfa pegol.
Therapeutic Indication
### Therapeutic indication Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Esperoct can be used for all age groups.
Therapeutic Area (MeSH)
ATC Code
B02BD02
ATC Item
coagulation factor VIII
Pharmacotherapeutic Group
Antihemorrhagics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Turoctocog alfa pegol | N/A | 培妥罗凝血素α |
EMA Name
Esperoct
Medicine Name
Esperoct
Aliases
N/ANo risk management plan link.
